Treatment of low-renin essential hypertension. Comparison of spironolactone and a hydrochlorothiazide-triamterene combination.
D000328:Adult; D000368:Aged; D000450:Aldosterone / Q000652:urine; D001794:Blood Pressure / Q000187:drug effects; D001806:Blood Urea Nitrogen; D002986:Clinical Trials as Topic; D003404:Creatinine / Q000097:blood; D004359:Drug Therapy, Combination; D005110:Extracellular Space / Q000187:drug effects; D005260:Female; D006801:Humans; D006852:Hydrochlorothiazide / Q000008:administration & dosage* / Q000494:pharmacology / Q000627:therapeutic use; D006973:Hypertension / Q000188:drug therapy*; D007258:Informed Consent; D008297:Male; D008875:Middle Aged; D010919:Placebos; D011187:Posture; D011188:Potassium / Q000097:blood; D012083:Renin / Q000097:blood*; D012964:Sodium / Q000097:blood; D013148:Spironolactone / Q000494:pharmacology / Q000627:therapeutic use*; D014223:Triamterene / Q000008:administration & dosage* / Q000494:pharmacology / Q000627:therapeutic use
D010919:Placebos; D006852:Hydrochlorothiazide; D013148:Spironolactone; D000450:Aldosterone; D012964:Sodium; D003404:Creatinine; D012083:Renin; D011188:Potassium; D014223:Triamterene